Editorial & Publishing Policies

Aim and Scope

Advances in Regenerative Biology is a new international peer-reviewed open access journal dedicated to publishing high quality research in the areas of developmental biology, stem cell biology, and regenerative medicine. The aim of the journal is to contribute to a better understanding of this broad field of research and provide a platform for the exchange of ideas and data on how novel observations and experimental results may translate into applications in the field of regenerative medicine.

One of our highest priorities is to improve the transparency and reproducibility of the published data. To this end, and so to guarantee the highest quality of the data presented, all papers are especially evaluated for their technical aspects, research design and analytical methods.

Topics of interest include

  • cellular and molecular mechanisms of development
  • morphogenesis
  • stem cell biology
  • embryonic stem cells
  • adult stem cells
  • cellular regeneration
  • pluripotency
  • stem cell differentiation
  • stem cell niches
  • tissue‐specific stem cells
  • germline stem cells
  • epigenetics
  • genome reprogramming
  • genome editing
  • gene therapy
  • nuclear transfer technology
  • stem cell‐based disease models
  • cell imaging
  • stem cell protocols
  • biomaterials
  • bioimplants
  • biofilms
  • bioimaging
  • tissue engineering and modeling
  • artificial organs
  • any aspect related to regenerative medicine

In order to make scientific and technological research more accessible to the civil society, authors are invited to contribute with a brief summary for a non-expert. This effort meets not only the interests of the science community but also those of civil society at large, the open access publication model being conducive to this effort.


EDITORIAL PROCESS

All submissions to Advances in Regenerative Biologyare initially evaluated by the scientific editors. As a main criterion for further handling, the editors will evaluate the technical aspects of the article, its research design, and analytical methods (including statistical analysis) to guarantee that experiments and data analysis have been rigorously conducted. Then, the editors will evaluate the relevance of the scientific data and the possible contribution to the areas of developmental biology, stem cell biology and regenerative medicine.  Papers failing to meet the journal standards will be returned to the authors without review within one week. If there is a clear interest in the data presented but the analytical methods are not appropriated accordingly to our standards, the authors will be invited to adapt the manuscript to our standards for a second editorial consideration. Otherwise, manuscripts will be sent to at least two reviewers who have agreed in advance to assess the paper rapidly, and an editorial decision should arrive within 3-4 weeks of the submission date. The authors will remain anonymous to the referees in order to remove unconscious biases during the peer-review process.

Accepted, typeset and proofread articles are published online with a DOI as soon as they become ready. It usually takes 3-4 weeks from acceptance to publication.

 

TYPES OF ARTICLES

Advances in Regenerative Biology welcomes high quality research under the format of original research articles, brief communications, protocols, and review articles. As a general requirement, all formats should include a title (250 characters or fewer), an abstract (maximum 250 words) - independently of the format. Supplementary data should be kept to a minimum. All authors are kindly invited to include in each submission a brief summary (maximum 350 words) written in a popular science fashion for a non-expert audience about the type of research, objectives and main conclusions. A brief description of each article type is provided below.

Original Research Articles, for conceptual advances regarding a biological question merging the areas of developmental biology, stem cell biology and regenerative medicine. Research papers should be as concise as possible and written in a style that is accessible to the broad scientific audience. As part of the general requirements, original research articles should include an introduction, material and methods, results, discussion, and references.

Brief Communications, for conceptual advances regarding a relevant biological question merging the areas of developmental biology, stem cell biology and regenerative medicine that can be presented within a shorter format. Brief communications should be as concise as possible and written in a style that is accessible to the broad scientific audience. As part of the general requirements, brief communications should include a brief introduction, material and methods, a combined section merging results and discussion, and references.

Protocols, for step-by-step descriptions of procedures for stem cell differentiation, which that the scientific community can apply in their own research. As part of the general requirements, a protocol article should include a brief introduction, material and methods, procedure (with critical steps highlighted) with information about timing and possible troubleshooting, a combined section merging results and discussion, and references.

Mini-Review Articles, should consist of a maximum of 8.000 characters with spaces excluding abstract and bibliography, providing new insights and current information of a particular topic, being well-focused and as concise as possible. Mini-Reviews should reflect the view of the authors highlighting aspects related to regenerative medicine.

Letter to the Editor, is presented in a flexible format that may include anything of interest to the journal’s readers. This format is not intended for full presentation of data. Correspondence should never exceed a maximum of 2.000 characters with spaces excluding bibliography, and the number of references should not exceed 10 references.

·    

 

Section Policies

Editorial

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Invited Editorials

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Mini Reviews

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Review Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Invited Review Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communication

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Position Papers

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Protocols

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All submissions to Advances in Regenerative Biology are initially evaluated by the scientific editors. As a main criterion for further handling, the editors will evaluate the technical aspects of the article, its research design, and analytical methods (including statistical analysis) to guarantee that experiments and data analysis have been rigorously conducted. Then, the editors will evaluate the relevance of the scientific data and the possible contribution to the areas of developmental biology, stem cell biology and regenerative medicine.  Papers failing to meet the journal standards will be returned to the authors without review within one week. If there is a clear interest in the data presented but the analytical methods are erratic, the authors will be invited to adapt the manuscript to our standards for a second editorial consideration. Otherwise, manuscripts will be sent to at least two reviewers who have agreed in advance to assess the paper rapidly.

Advances in Regenerative Biology has a 'double blind' review process: Authors are not told who reviewed their paper, and reviewers are not told who wrote the paper. Peer reviewers are informed of the identity of the authors immediately after the manuscript is either accepted or rejected. The referees’ identity remains unknown to the authors although it is up to the referee if he/she wants to contact the author at a later stage and reveal his/her identity. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s).

Peer reviewers will have six possible options, for each article:

  1. Accept manuscript (i.e. no need for any revision)
  2. Accept after revision (i.e. accepted if the author makes the requested revisions)
  3. Revise and resubmit (i.e. accepted or rejected after revisions have been made - paper will be sent out for another peer review round)
  4. Submit elsewhere (i.e. if the manuscript is better suited for another journal)
  5. Reject manuscript (i.e. if the manuscript is substandard)
  6. See comments (i.e. if the reviewer cannot choose from any of the above)

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard.

When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data or to identify areas where more data are needed. Even formal revision may be required if the language or style is sub-standard. To facilitate rapid publication, authors are given a maximum of 2 months for revision. After 2 months, revised manuscripts will be considered new submissions.

 

Publication Frequency

All articles published in Advances in Regenerative Biology are posted online immediately as they are ready for publication, i.e. after final proofreading. The journal does not collate numbered issues published regularly, only volumes per year, but all articles will be assigned a DOI number (Digital Object Identifier) whereby they become searchable and citable without delay.

 

Open Access Policy

Advances in Regenerative Biology is published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) License. Authors retain full copyright. See also the copyright section. 

Advances in Regenerative Biology is accessible via the journal’s website at www.regenerativebiology.net as well as via international search engines such as Google and Google Scholar.

 

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

In addition, all files will be archived with CLOCKSS and Portico.

 

Author Self-Archiving

Authors are permitted and encouraged to post any version of their manuscript to personal or institutional websites, in repositories and similar, prior to and after publication (while providing the bibliographic details of that publication).